CXApp Sees a Paradigm Shift with Agentic AI and Enterprise Adoption

CXApp Sees a Paradigm Shift with Agentic AI and Enterprise Adoption


The recent Q4 2025 earnings call for CXApp, a global AI-native workplace experience platform, has revealed a significant shift in the company's trajectory. As Chairman and CEO Khurram Sheikh emphasized during the conference call, 2026 marks a true inflection point for CXAI as it capitalizes on the convergence of three market forces: hybrid workplace orchestration, AI adoption, and indoor intelligence.

The company's Sky platform has been gaining momentum, with over 1 million users across 200+ cities, 50+ countries. This growth is attributed to its unique position at the intersection of these three trends. As Sheikh pointed out, CXApp is not chasing the market; rather, it's the market that's coming to them.

The company's pivot into agentic AI has been a crucial factor in its success. Agentic AI refers to the integration of AI agents with specific skills and expertise into various business functions. With Gartner predicting that 40% of enterprise apps will feature task-specific AI agents by the end of 2026, CXApp is well-positioned to capitalize on this trend.

The market's increasing demand for AI-driven solutions has led to significant growth in the AI agent market. According to estimates, the current market size stands at $7.8 billion and is projected to reach $52 billion by 2030. Moreover, Gen AI model spending alone is growing at a staggering 80% in 2026.

Enterprise adoption of AI has also seen significant growth. With 88% of organizations now reporting regular AI use in at least one business function, CXApp's Sky platform is poised to become an essential tool for enterprises looking to integrate AI into their operations.

CXApp's patent portfolio, which currently stands at 39 filed patents and 18 granted patents, provides a significant competitive moat. The company's emphasis on R&D has enabled it to stay ahead of the curve in terms of innovation and technology adoption.

The conference call also highlighted CXApp's commitment to security and compliance. With enterprise-grade certifications such as ISO 27001, SOC 2, and GDPR, the company's Sky platform is ready for global deployment by Fortune 500 enterprises.

Read more

Imunon's Transformative Year: Groundbreaking IMNN-001 Results Set New Standard for Ovarian Cancer Treatment

Imunon's Transformative Year: Groundbreaking IMNN-001 Results Set New Standard for Ovarian Cancer Treatment

Imunon, a pioneering biotechnology company, made history with its fourth quarter and full year 2025 financial results, showcasing a truly transformational year in the fight against ovarian cancer. The company's proprietary IL-12 immunotherapy, IMNN-001, has demonstrated unprecedented potential to redefine frontline treatment for women with newly diagnosed advanced

By Mason Lankes